Clinical Trial Update: Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors

View source ↗

Summary

A completed clinical trial from University Hospital, Bordeaux evaluating biomarkers that predict the efficacy of beta-blockers in PEComa and vascular pediatric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemangioma
• Pecoma

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: PEComa, Hemangioma | Status: COMPLETED